|
Volumn 14, Issue 9, 2013, Pages
|
Arsenic trioxide combination improves survival in APL.
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
ARSENIC TRIOXIDE;
ORGANOARSENIC DERIVATIVE;
OXIDE;
RETINOIC ACID;
HUMAN;
MORTALITY;
NOTE;
PROGNOSIS;
PROMYELOCYTIC LEUKEMIA;
REMISSION;
SURVIVAL RATE;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
ARSENICALS;
HUMANS;
LEUKEMIA, PROMYELOCYTIC, ACUTE;
OXIDES;
PROGNOSIS;
REMISSION INDUCTION;
SURVIVAL RATE;
TRETINOIN;
MLCS;
MLOWN;
|
EID: 84884776663
PISSN: None
EISSN: 14745488
Source Type: None
DOI: 10.1016/s1470-2045(13)70348-6 Document Type: Note |
Times cited : (4)
|
References (0)
|